87 related articles for article (PubMed ID: 9692947)
1. Homology model for oncostatin M based on NMR structural data.
Kitchen D; Hoffman RC; Moy FJ; Powers R
Biochemistry; 1998 Jul; 37(30):10581-8. PubMed ID: 9692947
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF).
Lovejoy B; Cascio D; Eisenberg D
J Mol Biol; 1993 Dec; 234(3):640-53. PubMed ID: 7504736
[TBL] [Abstract][Full Text] [Related]
3. The disulfide bond arrangement of leukemia inhibitory factor: homology to oncostatin M and structural implications.
Nicola NA; Cross B; Simpson RJ
Biochem Biophys Res Commun; 1993 Jan; 190(1):20-6. PubMed ID: 8422244
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.
Rose TM; Bruce AG
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8641-5. PubMed ID: 1717982
[TBL] [Abstract][Full Text] [Related]
5. Solution dynamics and secondary structure of murine leukemia inhibitory factor: a four-helix cytokine with a rigid CD loop.
Purvis DH; Mabbutt BC
Biochemistry; 1997 Aug; 36(33):10146-54. PubMed ID: 9254611
[TBL] [Abstract][Full Text] [Related]
6. Tertiary structural models for human interleukin-6 and evaluation by a sequence-structure compatibility method and NMR experimental information.
Sumikawa H; Fukuhara K; Suzuki E; Matsuo Y; Nishikawa K
FEBS Lett; 1997 Mar; 404(2-3):234-40. PubMed ID: 9119070
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
8. Structure of cytokine hydrophobic cores.
Denesyuk AI; Johnson MS; Zav'yalov VP; Korpela T
J Theor Biol; 1996 Jun; 180(4):297-307. PubMed ID: 8776464
[TBL] [Abstract][Full Text] [Related]
9. Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme.
Aritomi M; Kunishima N; Okamoto T; Kuroki R; Ota Y; Morikawa K
Nature; 1999 Oct; 401(6754):713-7. PubMed ID: 10537111
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
11. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the solution structure of human interleukin-4 determined by heteronuclear three-dimensional nuclear magnetic resonance techniques.
Redfield C; Smith LJ; Boyd J; Lawrence GM; Edwards RG; Gershater CJ; Smith RA; Dobson CM
J Mol Biol; 1994 Apr; 238(1):23-41. PubMed ID: 8145254
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of murine leukemia inhibitory factor.
Robinson RC; Grey LM; Staunton D; Stuart DI; Heath JK; Jones EY
Ann N Y Acad Sci; 1995 Jul; 762():179-87; discussion 187-8. PubMed ID: 7668528
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of human IL-13 and implication for receptor binding.
Moy FJ; Diblasio E; Wilhelm J; Powers R
J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
[TBL] [Abstract][Full Text] [Related]
15. Homology modelling and 1H NMR studies of human leukaemia inhibitory factor.
Smith DK; Treutlein HR; Maurer T; Owczarek CM; Layton MJ; Nicola NA; Norton RS
FEBS Lett; 1994 Aug; 350(2-3):275-80. PubMed ID: 7520873
[TBL] [Abstract][Full Text] [Related]
16. Circular permutation of granulocyte colony-stimulating factor.
Feng Y; Minnerly JC; Zurfluh LL; Joy WD; Hood WF; Abegg AL; Grabbe ES; Shieh JJ; Thurman TL; McKearn JP; McWherter CA
Biochemistry; 1999 Apr; 38(14):4553-63. PubMed ID: 10194377
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.
Robinson RC; Grey LM; Staunton D; Vankelecom H; Vernallis AB; Moreau JF; Stuart DI; Heath JK; Jones EY
Cell; 1994 Jul; 77(7):1101-16. PubMed ID: 8020098
[TBL] [Abstract][Full Text] [Related]
18. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
19. Resonance assignments, secondary structure and topology of leukaemia inhibitory factor in solution.
Hinds MG; Maurer T; Zhang JG; Nicola NA; Norton RS
J Biomol NMR; 1997 Feb; 9(2):113-26. PubMed ID: 9090127
[TBL] [Abstract][Full Text] [Related]
20. Tertiary structural models of human interleukin-6 and evaluation by comparison with X-ray and NMR structures.
Sumikawa H; Suzuki E
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):136-8. PubMed ID: 9468646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
